Cargando…
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
PURPOSE OF REVIEW: The current review discusses the importance and significance of differentiating monogenic familial hypercholesterolemia (FH) from polygenic hypercholesterolemia for clinical purpose. RECENT FINDINGS: Consistent scientific evidence have demonstrated that, compared to polygenic hype...
Autor principal: | Tandirerung, Fistra Janrio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729145/ https://www.ncbi.nlm.nih.gov/pubmed/36083530 http://dx.doi.org/10.1007/s11886-022-01783-5 |
Ejemplares similares
-
Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
por: Ma, Gary S., et al.
Publicado: (2023) -
Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019) -
Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities
por: Epstein, Elizabeth, et al.
Publicado: (2021) -
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
por: Arnold, Natalie, et al.
Publicado: (2022) -
Familial Hypercholesterolemia: Present and Future Management
por: Sjouke, B., et al.
Publicado: (2011)